lifestyle.goodsciencing.com

Author: UroGen Pharma Ltd.

UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 6, 2026
UroGen Announces ZUSDURI™ Launch is On-Track and Reports Fourth Quarter and Full Year 2025 Financial Results

March 2, 2026
UroGen Announces Refinanced Term Loan Agreement with Pharmakon Advisors

March 2, 2026
ZUSDURI™ Achieves Durable Complete Responses Across EORTC Risk Groups in Patients with Recurrent LG-IR-NMIBC

February 27, 2026
UroGen Pharma to Present at the TD Cowen 46th Annual Health Care Conference

February 24, 2026
UroGen Pharma to Report Fourth Quarter and Full-Year 2025 Financial Results on Monday, March 2, 2026

February 23, 2026
UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit

February 10, 2026